$NBIX NEUROCRINE BIOSCIENCES INC Insider Trading Week 50/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEUROCRINE BIOSCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEUROCRINE BIOSCIENCES INC in week 50/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | OBrien Christopher Flint | CHIEF MEDICAL OFFIC ... | Option Exercise | M | 2.59 | 20,000 | 51,800 | 55,000 | |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | OBrien Christopher Flint | CHIEF MEDICAL OFFIC ... | Sell | S | 24.02 | 20,000 | 480,400 | 95,644 | 115.6 K to 95.6 K (-17.29 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | OBrien Christopher Flint | CHIEF MEDICAL OFFIC ... | Buy | M | 2.59 | 20,000 | 51,800 | 116,544 | 96.5 K to 116.5 K (+20.72 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Option Exercise | M | 5.12 | 15,000 | 76,800 | 0 | |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Option Exercise | M | 5.12 | 14,474 | 74,107 | 15,000 | |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Option Exercise | M | 5.12 | 15,526 | 79,493 | 29,474 | |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Option Exercise | M | 2.59 | 25,000 | 64,750 | 160,000 | |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Sell | S | 24.01 | 15,000 | 360,150 | 180,952 | 196 K to 181 K (-7.65 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Buy | M | 5.12 | 15,000 | 76,800 | 195,952 | 181 K to 196 K (+8.29 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Sell | S | 23.24 | 30,000 | 697,200 | 180,952 | 211 K to 181 K (-14.22 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Buy | M | 5.12 | 30,000 | 153,600 | 210,952 | 181 K to 211 K (+16.58 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Sell | S | 23.24 | 25,000 | 581,000 | 180,952 | 206 K to 181 K (-12.14 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | PRESIDENT AND CEO | Buy | M | 2.59 | 25,000 | 64,750 | 205,952 | 181 K to 206 K (+13.82 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 110,000 | |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Option Exercise | M | 2.59 | 20,000 | 51,800 | 120,000 | |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 24.02 | 10,000 | 240,200 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Buy | M | 2.59 | 10,000 | 25,900 | 107,874 | 97.9 K to 107.9 K (+10.22 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 23.11 | 10,000 | 231,100 | 97,874 | 107.9 K to 97.9 K (-9.27 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Sell | S | 23.25 | 10,000 | 232,500 | 107,874 | 117.9 K to 107.9 K (-8.48 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Coughlin Timothy P | Chief Financial Off ... | Buy | M | 2.59 | 20,000 | 51,800 | 117,874 | 97.9 K to 117.9 K (+20.43 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 2.59 | 15,002 | 38,855 | 30,000 | |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 22.51 | 15,002 | 337,695 | 78,579 | 93.6 K to 78.6 K (-16.03 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 2.59 | 15,002 | 38,855 | 93,581 | 78.6 K to 93.6 K (+19.09 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Option Exercise | M | 2.59 | 14,706 | 38,089 | 30,000 | |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Sell | S | 22.50 | 14,706 | 330,885 | 77,058 | 91.8 K to 77.1 K (-16.03 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Buy | M | 2.59 | 14,706 | 38,089 | 91,764 | 77.1 K to 91.8 K (+19.08 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Gano Kyle | Chief Business Dev ... | Option Exercise | M | 5.00 | 4,957 | 24,785 | 0 | |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Gano Kyle | Chief Business Dev ... | Sell | S | 22.50 | 4,957 | 111,533 | 23,738 | 28.7 K to 23.7 K (-17.27 %) |
| Dec 19 2014 | NBIX | NEUROCRINE BIOSCIE ... | Gano Kyle | Chief Business Dev ... | Buy | M | 5.00 | 4,957 | 24,785 | 28,695 | 23.7 K to 28.7 K (+20.88 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | MOLLICA JOSEPH A | Director | Option Exercise | M | 4.76 | 20,000 | 95,200 | 0 | |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | MOLLICA JOSEPH A | Director | Payment of Exercise | F | 21.97 | 4,333 | 95,196 | 19,175 | 23.5 K to 19.2 K (-18.43 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | MOLLICA JOSEPH A | Director | Buy | M | 4.76 | 20,000 | 95,200 | 23,508 | 3.5 K to 23.5 K (+570.13 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.12 | 2,500 | 12,800 | 2,500 | |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 2.59 | 4,998 | 12,945 | 45,002 | |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.12 | 5,000 | 25,600 | 5,000 | |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 21.72 | 2,500 | 54,300 | 78,579 | 81.1 K to 78.6 K (-3.08 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.12 | 2,500 | 12,800 | 81,079 | 78.6 K to 81.1 K (+3.18 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 22.50 | 9,998 | 224,955 | 78,579 | 88.6 K to 78.6 K (-11.29 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.12 | 5,000 | 25,600 | 88,577 | 83.6 K to 88.6 K (+5.98 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 2.59 | 4,998 | 12,945 | 83,577 | 78.6 K to 83.6 K (+6.36 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Option Exercise | M | 5.12 | 2,500 | 12,800 | 2,500 | |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Option Exercise | M | 2.59 | 5,294 | 13,711 | 44,706 | |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Option Exercise | M | 5.12 | 5,000 | 25,600 | 5,000 | |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Sell | S | 21.71 | 2,500 | 54,275 | 77,058 | 79.6 K to 77.1 K (-3.14 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Buy | M | 5.12 | 2,500 | 12,800 | 79,558 | 77.1 K to 79.6 K (+3.24 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Sell | S | 22.50 | 10,294 | 231,615 | 77,058 | 87.4 K to 77.1 K (-11.78 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Buy | M | 5.12 | 5,000 | 25,600 | 87,352 | 82.4 K to 87.4 K (+6.07 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Buy | M | 2.59 | 5,294 | 13,711 | 82,352 | 77.1 K to 82.4 K (+6.87 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Gano Kyle | Chief Business Dev ... | Option Exercise | M | 5.00 | 4,043 | 20,215 | 4,957 | |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Gano Kyle | Chief Business Dev ... | Sell | S | 22.50 | 4,043 | 90,968 | 23,738 | 27.8 K to 23.7 K (-14.55 %) |
| Dec 15 2014 | NBIX | NEUROCRINE BIOSCIE ... | Gano Kyle | Chief Business Dev ... | Buy | M | 5.00 | 4,043 | 20,215 | 27,781 | 23.7 K to 27.8 K (+17.03 %) |